XML 147 R28.htm IDEA: XBRL DOCUMENT

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2024

Investments, All Other Investments [Abstract]

Schedule of Cash and Marketable Securities by Significant Investment Category

The following tables show the Company’s cash, cash equivalents, restricted cash, and marketable securities by significant investment category as of:

		September 30, 2024
		cost				Unrealized Gain/(Loss)				Fair Value				Cash and Cash Equivalents				Marketable Securities
Cash		$	11,561,000			$	-			$	11,561,000			$	11,561,000			$	-
Level 1
Money Market Funds			70,000				-				70,000				70,000				-
Marketable Securities			25,458,000				(18,195,000	)		$	7,263,000				-				7,263,000
Total		$	37,089,000			$	(18,195,000	)		$	18,894,000			$	11,631,000			$	7,263,000

		December 31, 2023
		Adjusted Cost				Unrealized Gain/(Loss)				Fair Value				Cash and Cash Equivalents				Marketable Securities
Cash		$	6,545,000			$	-			$	6,545,000			$	6,545,000			$	-
Level 1
Money Market Funds		$	70,000				-			$	70,000				70,000				-
Marketable Securities		$	27,304,000				(17,325,000	)		$	9,979,000				-				9,979,000
Total		$	33,919,000			$	(17,325,000	)		$	16,594,000			$	6,615,000			$	9,979,000